The Minister for Science and Culture, Gabriele Heinen-Kljajić, and the Minister for Economics, Employment and Traffic, Olaf Lies awarded the 1st prize of the Innovation Network Niedersachsen to YUMAB CEO Dr. Thomas Schirrmann and his colleagues at the Hannover Messe yesterday.
The Innovation Network Niedersachsen represents 275 technology transfer and economic development stakeholders. Its annual prize honours succesful cooperations between academia and industry.
YUMAB and the University of Braunschweig, which spun off the company, won the prize for their innovative approach to isolate human antibodies for drug development. Human antibodies represent today's fastest growing and economically most successful class of novel drugs and can be used against a vast diversity of diseases, ranging from cancer and autoimmune disorders to infections. Yumab provides human antibody candidates for drug development to pharma and biotech companies, and has already gained a substantial international panel of customers.
In her laudation, Minister Heinen-Kljajić appreciated the impact of antibodies for developing new medical treatments, in particular in personalized medicine. She also mentioned that the animal-free methods employed by Yumab perfectly match the goverment's goals to reduce animal experimentation. Minister Olaf Lies emphasized the importance of spinn-offs for the economy and acknowledged the cooperation of Yumab and University of Braunschweig as a good example.
Yumab CEO Dr. Thomas Schirrmann expressed his gratitude for the reward and the appreciation of the products and business strategy of Yumab by the heads of two ministries, and he emphasized the commitment of Yumab to expand it's facilities in Braunschweig.